- Home
- WVE vs CRSR Comparison
WVE vs CRSR Comparison
Compare WVE & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- CRSR
- Stock Information
- Founded
- WVE 2012
- CRSR 1994
- Country
- WVE Singapore
- CRSR United States
- Employees
- WVE N/A
- CRSR N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- CRSR Computer Manufacturing
- Sector
- WVE Health Care
- CRSR Technology
- Exchange
- WVE Nasdaq
- CRSR Nasdaq
- Market Cap
- WVE 915.6M
- CRSR 1.1B
- IPO Year
- WVE 2015
- CRSR 2020
- Fundamental
- Price
- WVE $7.22
- CRSR $9.18
- Analyst Decision
- WVE Strong Buy
- CRSR Buy
- Analyst Count
- WVE 11
- CRSR 6
- Target Price
- WVE $20.91
- CRSR $10.00
- AVG Volume (30 Days)
- WVE 1.1M
- CRSR 684.8K
- Earning Date
- WVE 05-08-2025
- CRSR 07-31-2025
- Dividend Yield
- WVE N/A
- CRSR N/A
- EPS Growth
- WVE N/A
- CRSR N/A
- EPS
- WVE N/A
- CRSR N/A
- Revenue
- WVE $104,939,000.00
- CRSR $1,348,872,000.00
- Revenue This Year
- WVE N/A
- CRSR $14.40
- Revenue Next Year
- WVE N/A
- CRSR $9.76
- P/E Ratio
- WVE N/A
- CRSR N/A
- Revenue Growth
- WVE N/A
- CRSR N/A
- 52 Week Low
- WVE $4.25
- CRSR $5.60
- 52 Week High
- WVE $16.74
- CRSR $13.02
- Technical
- Relative Strength Index (RSI)
- WVE 61.17
- CRSR 63.88
- Support Level
- WVE $5.98
- CRSR $8.93
- Resistance Level
- WVE $6.30
- CRSR $9.34
- Average True Range (ATR)
- WVE 0.33
- CRSR 0.37
- MACD
- WVE 0.14
- CRSR 0.04
- Stochastic Oscillator
- WVE 92.21
- CRSR 87.58
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.